I think you are confusing two different things:
Recruitment fee of 8 patients (ZLD is paying Emerald $99,920 - (available at Cannabis Access or Cannvalate for under 1/10th this price)
or
Clinical Research Costs for a whole clinical trial
If you read the text, it says very clearly that ZLD is responsible for getting their own Ethics approvals (HREC) done.
There are some serious questions about why ZLD is shelling money out to related entities like this.
Big question marks now:
1. Non-novel drugs
2. Underpowered clinical trials
3. No CTN numbers for any trials
4. Excessive fees paid to related parties
5. No dossiers collected by any regulatory bodies
Its looking more and more concerning.
- Forums
- ASX - By Stock
- ZLD
- Non-commercial prices for "research" being paid to closely related parties
Non-commercial prices for "research" being paid to closely related parties, page-9
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.0¢ |
Change
-0.030(4.29%) |
Mkt cap ! $7.602M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 67.0¢ | $1.548K | 2.246K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4350 | 67.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
72.0¢ | 229 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4350 | 0.670 |
3 | 12791 | 0.650 |
1 | 9000 | 0.600 |
1 | 1400 | 0.560 |
1 | 2000 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.720 | 229 | 1 |
0.735 | 13966 | 2 |
0.740 | 217 | 1 |
0.750 | 258 | 2 |
0.760 | 1154 | 2 |
Last trade - 15.45pm 13/09/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online